Global Information
회사소개 | 문의 | 비교리스트

세계의 반려동물용 헬스케어 시장(2022-2026년)

Global Companion Animal Healthcare Market 2022-2026

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2022년 07월 상품코드 1109489
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,551,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,682,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 반려동물용 헬스케어 시장(2022-2026년) Global Companion Animal Healthcare Market 2022-2026
발행일 : 2022년 07월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 반려동물용 헬스케어 시장 규모는 2022-2026년간 98억 2,000만 달러의 증가가 전망되며, 예측기간 중 CAGR로 9.25%의 성장이 예상됩니다.

시장을 견인하는 요인은 반려동물 사육률 상승, 마케팅 캠페인이나 포장 혁신, 인수공통감염증 만연 등을 들 수 있습니다.

세계의 반려동물용 헬스케어(Companion Animal Healthcare) 시장에 대해 조사했으며, 시장 규모와 전망, 제품별 시장 세분화, 지역별 상황, 성장 촉진요인이나 과제, 벤더 분석 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 상황

  • 시장 생태계

제3장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모 : 2021년
  • 시장 전망 : 2021-2026년 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 협상력
  • 판매자의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 상황

제5장 시장 세분화 : 제품별

  • 시장 내역
  • 제품별 비교
  • 의약품 : 시장 규모와 예측
  • 진단 : 시장 규모와 예측
  • 제품별 시장 기회

제6장 고객 상황

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측
  • 유럽 : 시장 규모와 예측
  • 아시아 : 시장 규모와 예측
  • 기타 지역 : 시장 규모와 예측
  • 미국 : 시장 규모와 예측
  • 독일 : 시장 규모와 예측
  • 영국 : 시장 규모와 예측
  • 캐나다 : 시장 규모와 예측
  • 중국 : 시장 규모와 예측
  • 지역 상황별 시장 기회

제8장 성장 촉진요인, 과제, 동향

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 상황

  • 개요
  • 벤더 상황
  • 혼란 상황
  • 업계 위험

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Bayer AG
  • C. H. Boehringer Sohn AG and Co. KG
  • Ceva Sante Animale
  • Dechra Pharmaceuticals Plc
  • Heska Corp.
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Merck and Co. Inc.
  • Virbac Group
  • Zoetis Inc.

제11장 부록

KSM 22.08.17

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Product ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Bayer AG - Overview
  • Exhibits86: Bayer AG - Business segments
  • Exhibits87: Bayer AG - Key offerings
  • Exhibits88: Bayer AG - Segment focus
  • Exhibits89: C. H. Boehringer Sohn AG and Co. KG - Overview
  • Exhibits90: C. H. Boehringer Sohn AG and Co. KG - Business segments
  • Exhibits91: C. H. Boehringer Sohn AG and Co. KG - Key news
  • Exhibits92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
  • Exhibits93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
  • Exhibits94: Ceva Sante Animale - Overview
  • Exhibits95: Ceva Sante Animale - Product / Service
  • Exhibits96: Ceva Sante Animale - Key offerings
  • Exhibits97: Dechra Pharmaceuticals Plc - Overview
  • Exhibits98: Dechra Pharmaceuticals Plc - Business segments
  • Exhibits99: Dechra Pharmaceuticals Plc - Key offerings
  • Exhibits100: Dechra Pharmaceuticals Plc - Segment focus
  • Exhibits101: Heska Corp. - Overview
  • Exhibits102: Heska Corp. - Business segments
  • Exhibits103: Heska Corp. - Key news
  • Exhibits104: Heska Corp. - Key offerings
  • Exhibits105: Heska Corp. - Segment focus
  • Exhibits106: IDEXX Laboratories Inc. - Overview
  • Exhibits107: IDEXX Laboratories Inc. - Business segments
  • Exhibits108: IDEXX Laboratories Inc. - Key news
  • Exhibits109: IDEXX Laboratories Inc. - Key offerings
  • Exhibits110: IDEXX Laboratories Inc. - Segment focus
  • Exhibits111: Indian Immunologicals Ltd. - Overview
  • Exhibits112: Indian Immunologicals Ltd. - Product / Service
  • Exhibits113: Indian Immunologicals Ltd. - Key offerings
  • Exhibits114: Merck and Co. Inc. - Overview
  • Exhibits115: Merck and Co. Inc. - Business segments
  • Exhibits116: Merck and Co. Inc. - Key news
  • Exhibits117: Merck and Co. Inc. - Key offerings
  • Exhibits118: Merck and Co. Inc. - Segment focus
  • Exhibits119: Virbac Group - Overview
  • Exhibits120: Virbac Group - Business segments
  • Exhibits121: Virbac Group - Key news
  • Exhibits122: Virbac Group - Key offerings
  • Exhibits123: Virbac Group - Segment focus
  • Exhibits124: Zoetis Inc. - Overview
  • Exhibits125: Zoetis Inc. - Business segments
  • Exhibits126: Zoetis Inc. - Key news
  • Exhibits127: Zoetis Inc. - Key offerings
  • Exhibits128: Zoetis Inc. - Segment focus
  • Exhibits129: Inclusions checklist
  • Exhibits130: Exclusions checklist
  • Exhibits131: Currency conversion rates for US$
  • Exhibits132: Research methodology
  • Exhibits133: Validation techniques employed for market sizing
  • Exhibits134: Information sources
  • Exhibits135: List of abbreviations

Technavio has been monitoring the companion animal healthcare market and it is poised to grow by $ 9.82 bn during 2022-2026, accelerating at a CAGR of 9.25% during the forecast period. Our report on the companion animal healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising pet ownership, marketing campaigns and packaging innovations, and the growing prevalence of zoonotic diseases.

The companion animal healthcare market analysis includes product segment and geographic landscape.

Technavio's companion animal healthcare market is segmented as below:

By Product

  • pharmaceuticals
  • diagnostics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising awareness about pet insurance as one of the prime reasons driving the companion animal healthcare market growth during the next few years. Also, growing innovation in animal wound dressing techniques and increasing instances of mergers and acquisitions (M&A) among vendors will lead to sizable demand in the market.

Technavio presents a detailed structure of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters. Our report on the companion animal healthcare market covers the following areas:

  • Companion animal healthcare market sizing
  • Companion animal healthcare market forecast
  • Companion animal healthcare market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal healthcare market vendors that include Agrolabo Spa, Bayer AG, C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX Laboratories Inc., Indian Immunologicals Ltd., Innovate, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc. Also, the companion animal healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed market picture through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Pharmaceuticals - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
  • 5.4 Diagnostics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Bayer AG
  • Exhibit 85: Bayer AG - Overview
  • Exhibit 86: Bayer AG - Business segments
  • Exhibit 87: Bayer AG - Key offerings
  • Exhibit 88: Bayer AG - Segment focus
  • 10.4 C. H. Boehringer Sohn AG and Co. KG
  • Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
  • Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
  • Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
  • Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
  • Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
  • 10.5 Ceva Sante Animale
  • Exhibit 94: Ceva Sante Animale - Overview
  • Exhibit 95: Ceva Sante Animale - Product / Service
  • Exhibit 96: Ceva Sante Animale - Key offerings
  • 10.6 Dechra Pharmaceuticals Plc
  • Exhibit 97: Dechra Pharmaceuticals Plc - Overview
  • Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
  • Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
  • Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
  • 10.7 Heska Corp.
  • Exhibit 101: Heska Corp. - Overview
  • Exhibit 102: Heska Corp. - Business segments
  • Exhibit 103: Heska Corp. - Key news
  • Exhibit 104: Heska Corp. - Key offerings
  • Exhibit 105: Heska Corp. - Segment focus
  • 10.8 IDEXX Laboratories Inc.
  • Exhibit 106: IDEXX Laboratories Inc. - Overview
  • Exhibit 107: IDEXX Laboratories Inc. - Business segments
  • Exhibit 108: IDEXX Laboratories Inc. - Key news
  • Exhibit 109: IDEXX Laboratories Inc. - Key offerings
  • Exhibit 110: IDEXX Laboratories Inc. - Segment focus
  • 10.9 Indian Immunologicals Ltd.
  • Exhibit 111: Indian Immunologicals Ltd. - Overview
  • Exhibit 112: Indian Immunologicals Ltd. - Product / Service
  • Exhibit 113: Indian Immunologicals Ltd. - Key offerings
  • 10.10 Merck and Co. Inc.
  • Exhibit 114: Merck and Co. Inc. - Overview
  • Exhibit 115: Merck and Co. Inc. - Business segments
  • Exhibit 116: Merck and Co. Inc. - Key news
  • Exhibit 117: Merck and Co. Inc. - Key offerings
  • Exhibit 118: Merck and Co. Inc. - Segment focus
  • 10.11 Virbac Group
  • Exhibit 119: Virbac Group - Overview
  • Exhibit 120: Virbac Group - Business segments
  • Exhibit 121: Virbac Group - Key news
  • Exhibit 122: Virbac Group - Key offerings
  • Exhibit 123: Virbac Group - Segment focus
  • 10.12 Zoetis Inc.
  • Exhibit 124: Zoetis Inc. - Overview
  • Exhibit 125: Zoetis Inc. - Business segments
  • Exhibit 126: Zoetis Inc. - Key news
  • Exhibit 127: Zoetis Inc. - Key offerings
  • Exhibit 128: Zoetis Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 129: Inclusions checklist
  • Exhibit 130: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 131: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 132: Research methodology
  • Exhibit 133: Validation techniques employed for market sizing
  • Exhibit 134: Information sources
  • 11.5 List of abbreviations
  • Exhibit 135: List of abbreviations
Back to Top
전화 문의
F A Q